MCTA — CHARMING MEDICAL LTD
As of Q2 2026, 2 SEC-registered investment managers reported holding MCTA (CHARMING MEDICAL LTD) in their latest 13F filings, with a combined reported value of $1.03M across 35.00K shares. That is -2.0% by share count (-700 shares) versus the previous quarter, while reported value moved -2.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
MCTA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 24.25K | $711.83K | 0.00% | Reduce |
| Geode Capital Management history | 10.75K | $315.62K | 0.00% | Hold |
Q1 2026 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 24.95K | $732.38K | 0.00% | Reduce |
| Geode Capital Management history | 10.75K | $315.62K | 0.00% | Hold |
Q4 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| UBS Group AG history | 28.25K | $829.25K | 0.00% | New |
| Geode Capital Management history | 10.75K | $315.62K | 0.00% | New |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 2 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 |
|---|---|---|---|
| UBS Group AG | 24.25K | 24.95K | 28.25K |
| Geode Capital Management | 10.75K | 10.75K | 10.75K |